Effect of Shampakadi Kwatha in the management of Vatrakta w.s.r to Hyperuricemia
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseasesHealth Condition 2: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
- Registration Number
- CTRI/2023/01/049163
- Lead Sponsor
- Principal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) Patients of either gender in the age group between 20-70 years.
2) Patients having serum uric acid level level more than 7mg/dl (male) and more than 6mg/dl (female) with or without any associated features of joint inflammation.
1) Patient not willing for the trial.
2) Patient below age of 20 years and above 70 years of age.
3) Patient suffering from any other form of arthritis like osteoarthritis, Tubercular arthritis, Rheumatoid etc.
4) Patient suffering from chronic renal, respiratory, cardiac and hepatic disorders.
5)Patient having malignant disorder.
6) Patients who has completed participation in any other clinical trial during the past 3 months.
7) Any condition which the investigator thinks may comprise with the safety of the subject.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the clinical efficacy of Shampakadi Kwatha in the management of Vatarakta w.s.r. to Hyperuricemia. <br/ ><br>Relief in symptoms of Vatrkata after intervention of Shampakadi kwatha <br/ ><br>Sandhishoola-joint pain <br/ ><br>Sandhishotha-Sweling of the joint <br/ ><br>Raga/Redness <br/ ><br>Twakavaivarnya/discoloration of skin <br/ ><br>Sparasashyata/tenderness <br/ ><br>Vidaha- Burning sensation <br/ ><br>Timepoint: Duration of trial : 6 weeks <br/ ><br>Follow up : After every 2 weeks till the completion of trial <br/ ><br>Dosage : Shampakadi kwatha â?? 50 ml Twice a day <br/ ><br>Route of administration : Oral <br/ ><br> <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method To assess the clinical safety and adverse effects of Shampakadi Kwath. Improving quality of lifeTimepoint: At the 4weeks, 6 weeks and remain connected with telephonically to know the A.D.Rs if there is any after completion of trial